FIELD: chemistry.
SUBSTANCE: invention relates to crystalline forms I and II of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate. The invention also relates to pharmaceutical composition for treatment of CNS diseases, associated with cognitive disorders, which contains crystalline form I or II, to method for obtaining pharmaceutical composition and to method for obtaining crystalline form I.
EFFECT: novel crystalline forms of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride in form of monohydrate, which are stable and have low hygroscopicity, have been obtained.
10 cl, 6 dwg, 9 tbl, 12 ex
Title | Year | Author | Number |
---|---|---|---|
METHODS FOR COGNITIVE FUNCTION SUPPORT, TREATMENT OR IMPROVEMENT | 2013 |
|
RU2635522C2 |
NOVEL HETEROARENE ANTHRACENEDIONE-BASED G-QUADRUPLEX LIGANDS INHIBITING TUMOUR CELL GROWTH | 2013 |
|
RU2527459C1 |
SELECTIVE LIGANDS OF G-QUADRUPLEX STRUCTURES OF NUCLEIC ACIDS | 2015 |
|
RU2588131C1 |
2-[4-(METHYLAMINOMETHYL)PHENYL]-5-FLUORO-BENZOFURAN-7-CARBOXAMIDE HYDROCHLORIDE POLYMORPHOUS, METHOD FOR ITS PRODUCTION AND APPLICATION | 2018 |
|
RU2783418C1 |
METHOD OF SYNTHESIS OF CRYSTALLINE SOLVATE, CRYSTALLINE SOLVATE OF 6-HYDROXY-2-(4-HYDROXYPHENYL)-3-[4-(2-PIPERIDINEETH- -OXY)BENZOYL]BENZO[B]THIOPHENE HYDROCHLORIDE | 1995 |
|
RU2108331C1 |
TREATING COGNITIVE DISORDERS WITH (R)-7-CHLOR-N-(QUINUCLIDIN-3-YL) BENZO[b] THIOPHEN-2-CARBOXAMIDE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS | 2009 |
|
RU2532327C2 |
NONSOLVATED CRYSTALLINE 6-HYDROXY-2-(4-HYDROXYPHENYL)-3-[4-(2- -PIPERIDINOETHOXY)-BENZOYL]-BENZO-[B]-THIOPHENE HYDROCHLORIDE SHOWING ANTIESTROGENIC AND ANTIANDROGENIC ACTIVITY, PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2104278C1 |
TREATMENT OF COGNITIVE DISORDERS WITH (R)-7-CHLORO-N-(QUINUCLIDIN-3-YL)BENZO[B]THIOPHENE-2-CARBOXAMIDE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | 2014 |
|
RU2662560C2 |
CRYSTALLINE FORMS OF THE TLR7/TLR8 INHIBITOR | 2019 |
|
RU2792005C2 |
CRYSTALLINE (2S,4R)-5-(5'-CHLOR-2'-FLUORO-[1,1'-BIPHENYL]-4-YL)-2-(ETHOXYMETHYL)-4-(3-HYDROXYISOXAZOL-5-CARBOXAMIDO)-2-METHYLPENTANIC ACID AND ITS APPLICATIONS | 2017 |
|
RU2756223C2 |
Authors
Dates
2016-03-20—Published
2011-05-17—Filed